Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.110
-0.050 (-2.31%)
At close: Dec 5, 2025, 4:00 PM EST
2.100
-0.010 (-0.47%)
After-hours: Dec 5, 2025, 7:51 PM EST
Cardiff Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 142 | 289 | 66 | 63 | 252 | 635 | |
| Market Cap Growth | 7.76% | 336.64% | 5.71% | -75.20% | -60.31% | 6519.33% | |
| Enterprise Value | 83 | 233 | -13 | -49 | 121 | 600 | |
| Last Close Price | 2.11 | 4.34 | 1.48 | 1.40 | 6.01 | 17.99 | |
| PS Ratio | 267.60 | 422.72 | 135.50 | 162.04 | 702.51 | 1736.31 | |
| PB Ratio | 2.90 | 3.48 | 0.95 | 0.59 | 1.80 | 4.96 | |
| P/TBV Ratio | 2.91 | 3.48 | 0.95 | 0.59 | 1.80 | 4.96 | |
| EV/Sales Ratio | 164.77 | 340.75 | - | - | 338.28 | 1640.66 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | |
| Quick Ratio | 4.14 | 6.92 | 7.25 | 13.58 | 21.55 | 21.46 | |
| Current Ratio | 4.20 | 7.08 | 7.42 | 14.25 | 22.28 | 21.79 | |
| Return on Equity (ROE) | -102.71% | -59.51% | -47.07% | -31.37% | -21.07% | -28.50% | |
| Return on Assets (ROA) | -52.99% | -34.01% | -28.69% | -18.77% | -12.69% | -16.14% | |
| Return on Capital (ROIC) | -66.55% | -38.89% | -31.37% | -19.75% | -13.23% | -17.28% | |
| Return on Capital Employed (ROCE) | -109.40% | -58.10% | -63.80% | -36.80% | -20.20% | -14.80% | |
| Earnings Yield | -35.49% | -15.74% | -62.67% | -61.88% | -11.22% | -3.04% | |
| FCF Yield | -29.74% | -13.08% | -47.59% | -55.68% | -9.22% | -2.60% | |
| Buyback Yield / Dilution | -40.37% | -6.65% | -2.47% | -11.71% | -86.97% | -249.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.